{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/55154-5035#drug","name":"MiraLAX","alternateName":"Polyethylene Glycol 3350","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"55154-5035"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA022015"},{"@type":"PropertyValue","propertyID":"UNII","value":"G2M7P15E5P"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"1771d3bf-954d-49ea-b260-3d356e5dcfa5"}],"activeIngredient":"POLYETHYLENE GLYCOL 3350","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Cardinal Health 107, LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN OTC DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA022015","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1771d3bf-954d-49ea-b260-3d356e5dcfa5","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55154-5035"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T08:28:47.546Z"}}